Belloy and colleagues show that the impact of APOE genotype on Alzheimer’s disease is influenced by age, sex, race, ethnicity, and ancestry. These findings have significant implications for treatment-related decision-making and clinical trials.
This Genetic Variant Raises the Risk for Alzheimer’s Disease, Who is Most at Risk (Links to an external site)
